MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced that at its Annual Meeting of Stockholders held earlier today Mr. Kenneth B. Lee, Jr. was elected to the Company’s Board of Directors as an outside director. Mr. Lee will also serve on the Company’s Audit Committee. Additionally, at today’s meeting all existing ten members of the Company’s Board of Directors were re-elected. OSI also announced that, in accordance with the Company’s Board retirement age policy, G. Morgan Browne and Walter M. Lovenberg, Ph.D., did not stand for re-election. OSI currently has eleven directors serving on its board, ten of which are outside directors.
